Newsletter March 2018 No.184
Top News
"Regular Chairman's Press Conference" Held
On January 16, 2018, the JPMA held its “Regular Chairman’s Press Conference” at the Nomura Conference Plaza Nihonbashi (Chuo Ward, Tokyo).At the press conference, Yoshihiko Hatanaka, Chairman of the JPMA, explained the “Basic Stance of the Research-and-Development-Oriented Pharmaceutical Industry” and the “JPMA’s Views on Fundamental Reform of the Drug Pricing System,” as well as the “Progress on the JPMA’s Priority Issues for Fiscal Year 2017.”Approximately 50 members of the press attended, and a lively question-and-answer session took place, focusing primarily on the reform of the drug pricing system. The details of the session are presented below.
Topics
- CMC Strategy Forum Japan 2017" was held
- The 5th Taiwan-Japan Pharmaceutical Exchange Conference" was held
- UHC Forum 2017 Side Event" Held Promoting Sustainable UHC by Improving Access to Healthcare for Non-Communicable Diseases
- Held the "23rd Environmental Safety Seminar
- Symposium on Sharing of Individual Subject Data in Clinical Trials (CTDS) to be held Theme: "Current Status of Progressing CTDS and Methodologies for Data De-identification
- JPMA special program: TV Kumamoto "Kiirinase! Kikinase! ～TV Kumamoto "Know nase! Kikin nase! - Taga ga kikinaru okusuri jijo" (The situation of pharmaceuticals that you are interested in)
Policy Research Institute
From JPMA
Aiming for an Industry with Higher Drug Discovery Capability